1 results match your criteria: "Department of Internal Medicine Osaka Medical and Pharmaceutical University 2-7 Daigaku-cho[Affiliation]"
Type 1 diabetes related to immune checkpoint inhibitors.
Best Pract Res Clin Endocrinol Metab
May 2022
Department of Internal Medicine Osaka Medical and Pharmaceutical University 2-7 Daigaku-cho, Takatsuki 569-8686, Japan. Electronic address:
Type 1 diabetes, in part, has been recently reported as a side effect of immune checkpoint inhibitors (ICIs). The frequency of type 1 diabetes related to ICIs is estimated to be ∼3.5%.
View Article and Find Full Text PDF